BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9837821)

  • 1. The Ashkenazic Jewish Bloom syndrome mutation blmAsh is present in non-Jewish Americans of Spanish ancestry.
    Ellis NA; Ciocci S; Proytcheva M; Lennon D; Groden J; German J
    Am J Hum Genet; 1998 Dec; 63(6):1685-93. PubMed ID: 9837821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
    Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
    Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population.
    Li L; Eng C; Desnick RJ; German J; Ellis NA
    Mol Genet Metab; 1998 Aug; 64(4):286-90. PubMed ID: 9758720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid method for detecting the predominant Ashkenazi Jewish mutation in the Bloom's syndrome gene.
    Straughen JE; Johnson J; McLaren D; Proytcheva M; Ellis N; German J; Groden J
    Hum Mutat; 1998; 11(2):175-8. PubMed ID: 9482582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
    Roa BB; Savino CV; Richards CS
    Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping.
    Mitra N; Ye TZ; Smith A; Chuai S; Kirchhoff T; Peterlongo P; Nafa K; Phillips MS; Offit K; Ellis NA
    Cancer Res; 2004 Nov; 64(21):8116-25. PubMed ID: 15520224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage disequilibrium between the FES, D15S127, and BLM loci in Ashkenazi Jews with Bloom syndrome.
    Ellis NA; Roe AM; Kozloski J; Proytcheva M; Falk C; German J
    Am J Hum Genet; 1994 Sep; 55(3):453-60. PubMed ID: 8079989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Bloom syndrome heterozygotes among Ashkenazi Jews.
    Oddoux C; Clayton CM; Nelson HR; Ostrer H
    Am J Hum Genet; 1999 Apr; 64(4):1241-3. PubMed ID: 10090915
    [No Abstract]   [Full Text] [Related]  

  • 9. Syndrome-causing mutations of the BLM gene in persons in the Bloom's Syndrome Registry.
    German J; Sanz MM; Ciocci S; Ye TZ; Ellis NA
    Hum Mutat; 2007 Aug; 28(8):743-53. PubMed ID: 17407155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLM heterozygosity and the risk of colorectal cancer.
    Gruber SB; Ellis NA; Scott KK; Almog R; Kolachana P; Bonner JD; Kirchhoff T; Tomsho LP; Nafa K; Pierce H; Low M; Satagopan J; Rennert H; Huang H; Greenson JK; Groden J; Rapaport B; Shia J; Johnson S; Gregersen PK; Harris CC; Boyd J; Rennert G; Offit K
    Science; 2002 Sep; 297(5589):2013. PubMed ID: 12242432
    [No Abstract]   [Full Text] [Related]  

  • 11. The Bloom's syndrome gene product is homologous to RecQ helicases.
    Ellis NA; Groden J; Ye TZ; Straughen J; Lennon DJ; Ciocci S; Proytcheva M; German J
    Cell; 1995 Nov; 83(4):655-66. PubMed ID: 7585968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relatively common mutations of the Bloom syndrome gene in the Japanese population.
    Kaneko H; Isogai K; Fukao T; Matsui E; Kasahara K; Yachie A; Seki H; Koizumi S; Arai M; Utunomiya J; Miki Y; Kondo N
    Int J Mol Med; 2004 Sep; 14(3):439-42. PubMed ID: 15289897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
    Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
    Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bloom syndrome].
    Kondo N
    Nihon Rinsho; 2000 Jul; 58(7):1460-6. PubMed ID: 10921324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BLM (RCQL2) or Bloom Syndrome].
    Soussi T
    Bull Cancer; 2001 Feb; 88(2):129-30. PubMed ID: 11291661
    [No Abstract]   [Full Text] [Related]  

  • 16. The DNA helicase activity of BLM is necessary for the correction of the genomic instability of bloom syndrome cells.
    Neff NF; Ellis NA; Ye TZ; Noonan J; Huang K; Sanz M; Proytcheva M
    Mol Biol Cell; 1999 Mar; 10(3):665-76. PubMed ID: 10069810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of Bloom syndrome (BS) causing mutations in the BLM helicase domain.
    Rong SB; Väliaho J; Vihinen M
    Mol Med; 2000 Mar; 6(3):155-64. PubMed ID: 10965492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of BLM (the causative gene for Bloom syndrome) and screening of Bloom syndrome.
    Morimoto W; Kaneko H; Isogai K; Kasahara K; Kondo N
    Int J Mol Med; 2002 Jul; 10(1):95-9. PubMed ID: 12060858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of Bloom's syndrome.
    Ellis NA; German J
    Hum Mol Genet; 1996; 5 Spec No():1457-63. PubMed ID: 8875252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers.
    Schayek H; Laitman Y; Katz LH; Pras E; Ries-Levavi L; Barak F; Friedman E
    Isr Med Assoc J; 2017 Jun; 19(6):365-367. PubMed ID: 28647934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.